Catalyst Pharmaceuticals Inc (CPRX)

1.16
0.04 3.60
NASDAQ : Health Care
Prev Close 1.12
Open 1.15
Day Low/High 1.10 / 1.17
52 Wk Low/High 0.51 / 5.46
Volume 307.78K
Avg Volume 1.01M
Exchange NASDAQ
Shares Outstanding 82.87M
Market Cap 95.30M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results And Provides Corporate Update

Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results And Provides Corporate Update

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 triggering breakout trades.

One Reason Why Catalyst Pharmaceuticals (CPRX) Stock Is Jumping Today

One Reason Why Catalyst Pharmaceuticals (CPRX) Stock Is Jumping Today

Catalyst Pharmaceuticals' (CPRX) stock rating was boosted to 'overweight' at Piper Jaffray on Wednesday.

These 7 Stocks Under $10 Could Make You a Lot of Money

These 7 Stocks Under $10 Could Make You a Lot of Money

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results And Provides Product Development Update

Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results And Provides Product Development Update

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

Catalyst Pharmaceuticals Announces Agreement With FDA On Confirmatory Phase 3 Study Protocol For Firdapse In Lambert-Eaton Myasthenic Syndrome

Catalyst Pharmaceuticals Announces Agreement With FDA On Confirmatory Phase 3 Study Protocol For Firdapse In Lambert-Eaton Myasthenic Syndrome

Reorganized operations plan projects that current capital resources are adequate to reach NDA acceptance

Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results And Provides Corporate Update

Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results And Provides Corporate Update

Company to Host Quarterly Conference Call at 8:30 am EDT Tomorrow

Anavex Plays the Orphan Drug Stock Promotion Game

Anavex Plays the Orphan Drug Stock Promotion Game

Too many investors have a fundamental misunderstanding about the significance of orphan drug designation. I should say, insignificance, because the FDA delineation, on its own, means very little.

Catalyst Pharmaceuticals Announces Fourth Quarter And Year-End 2015 Financial Results

Catalyst Pharmaceuticals Announces Fourth Quarter And Year-End 2015 Financial Results

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow